Search

Your search keyword '"Szucs, Gabriella"' showing total 109 results

Search Constraints

Start Over You searched for: Author "Szucs, Gabriella" Remove constraint Author: "Szucs, Gabriella"
109 results on '"Szucs, Gabriella"'

Search Results

3. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

10. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

11. An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud’s phEnomenon (SUNSHINE survey)

17. Associations of vascular and bone status in arthritis patients

18. Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients

21. Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis

22. Prolactin and Autoimmunity

23. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

26. Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis

27. Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma Trials and Research cohort of patients with systemic sclerosis

30. Off-label use of rituximab for systemic lupus erythematosus in Europe

31. A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis.

32. Update of EULAR recommendations for the treatment of systemic sclerosis

33. Mapping and predicting mortality from systemic sclerosis

34. EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis

35. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis: results from the International Scleroderma Renal Crisis Survey

38. Hyperferritinemia is Associated with Serologic Antiphospholipid Syndrome in SLE Patients

39. Prolactin and Autoimmunity

43. Update of EULAR recommendations for the treatment of systemic sclerosis

44. Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B cell depletion.

45. Malignancy or inflammation? A case report of a young man with fever of unknown origin.

46. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.

47. Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage?

48. Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis.

49. Cutaneous vasculitis as an initiating paraneoplastic symptom in Hodgkin lymphoma.

50. Determination of ligand binding capacity of soluble Fc gamma RII and Fc gamma RIII in sera of patients with SLE.

Catalog

Books, media, physical & digital resources